Malaria Clinical Trials: Active Studies by Market and Country

• 13markets with active trials
• 124active studies on Malaria
• 24of our places with active trials

Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, worldwide. Retrieved 12 Nov 2026.

1. 1Malaria124Malaria: See them on ClinicalTrials.gov (opens in a new tab)
2. 2Malaria Vaccines33Malaria Vaccines: See them on ClinicalTrials.gov (opens in a new tab)
3. 3Plasmodium vivax Malaria27Plasmodium vivax Malaria: See them on ClinicalTrials.gov (opens in a new tab)
4. 4Malaria in Pregnancy12Malaria in Pregnancy: See them on ClinicalTrials.gov (opens in a new tab)
5. 5Severe Malaria8Severe Malaria: See them on ClinicalTrials.gov (opens in a new tab)
6. 6Malaria Surveillance5Malaria Surveillance: See them on ClinicalTrials.gov (opens in a new tab)
7. 7Seasonal Malaria Chemoprevention4Seasonal Malaria Chemoprevention: See them on ClinicalTrials.gov (opens in a new tab)
8. 8Antimalarial Drug Resistance3Antimalarial Drug Resistance: See them on ClinicalTrials.gov (opens in a new tab)
9. 9Mass Drug Administration for Malaria3Mass Drug Administration for Malaria: See them on ClinicalTrials.gov (opens in a new tab)
10. 10Childhood Malaria2Childhood Malaria: See them on ClinicalTrials.gov (opens in a new tab)
11. 11Perennial Malaria Chemoprevention2Perennial Malaria Chemoprevention: See them on ClinicalTrials.gov (opens in a new tab)
12. 12Indoor Residual Spraying1Indoor Residual Spraying: See them on ClinicalTrials.gov (opens in a new tab)
13. 13Malaria Rapid Diagnostic Tests1Malaria Rapid Diagnostic Tests: See them on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, worldwide. Retrieved 12 Nov 2026.

• Intermittent Preventive Treatment of Malaria in School-age Children to Decrease Community Transmission

  NCT07246525Malaria

• Host and Parasite Factors That Influence Susceptibility to Malaria Infection and Disease During Pregnancy and Early Childhood in Ouelessebougou and Bamako, Mali

  NCT01168271Malaria

• Clinical Study to Assess Minimum Mosquito Bites for P. Vivax Infection in Thai Adults

  NCT07257965Malaria

• Transmission-Blocking Vaccine Pvs230D1-EPA/Matrix-M in Healthy Malaria-Naive Adults Using a Plasmodium Vivax Controlled Human Malaria Infection and Transmission Model

  NCT07930585Malaria Vaccines

• The Effects of Iron Treatment on Vaccine Immunogenicity in Kenyan Infants With Iron Deficiency

  NCT06816524Malaria Vaccines

• Safety, Tolerability and Efficacy of PfSPZ-LARC2 Vaccine Against CHMI in Malaria-Naïve Adults

  NCT06862453Malaria Vaccines

• Positron Emission Tomography and Organ-Specific Changes in Participants Co-Enrolled in NIH Studies of Plasmodium Vivax Controlled Human Malaria Infection

  NCT07859800Plasmodium vivax Malaria

• Focal Mass Drug Administration for the Prevention of Malaria in Pregnancy

  NCT07021430Malaria in Pregnancy

• Improving Neonatal Health Through Rapid Malaria Testing in Early Pregnancy With High-Sensitivity Diagnostics

  NCT05757167Malaria in Pregnancy

• IGHID 12334 - After the Flood: Optimal Strategies to Prevent Malaria Epidemics Caused by Severe Flooding

  NCT06870344Severe Malaria

• Platelet-Directed Whole Blood Transfusion Strategy for Malaria

  NCT05711485Severe Malaria

• Post-discharge Malaria Chemoprevention Implementation Trial in Benin

  NCT06601712Severe Malaria

• Malaria Molecular Surveillance in Mozambique (Phase 2)

  NCT06529237Malaria Surveillance

• OPTIMAL LEAP: Optimizing Dihydroartemisinin-Piperaquine IPTsc Intervals to Advance Learning, Executive Function, Attendance, and Antimalarial Resistance Surveillance in Kenyan Schoolchildren

  NCT07798583Malaria Surveillance

• Surveillance of AMR in DRC

  NCT06821282Malaria Surveillance

• Comparison of Two Strategies for Administering the R21-Matrix M Vaccine in a Context of Seasonal Malaria Transmission in Chad

  NCT07038837Seasonal Malaria Chemoprevention

• Leveraging the Seasonal Malaria Chemoprevention Platform to Address Malaria and Malnutrition

  NCT06599593Seasonal Malaria Chemoprevention

• MDA and Targeted Control Against Plasmodium Carriage in the Sahel

  NCT07281443Seasonal Malaria Chemoprevention

• Factors Influencing Adoption of a Novel Malaria Treatment in Côte d'Ivoire, Ghana, and Rwanda

  NCT07896746Antimalarial Drug Resistance

• FocaL Mass Drug Administration for Vivax Malaria Elimination

  NCT05690841Mass Drug Administration for Malaria

• Assessing the Feasibility of Combining Dihydroartemisinin Piperaquine and Primaquine for Malaria Mass Drug Administration in High Endemic Communities in the Eastern Region of Ghana

  NCT07389057Mass Drug Administration for Malaria

• Perennial Malaria Chemoprevention in the Malaria Vaccine Era

  NCT07322068Perennial Malaria Chemoprevention

• Perennial Malaria Chemoprevention (PMC) Effect Study

  NCT06155448Perennial Malaria Chemoprevention

• Long-acting Spatial Emanators / Repellents (LASER)

  NCT07387341Indoor Residual Spraying

Source: ClinicalTrials.gov, Study records, newest update first. Retrieved 12 Nov 2026.

• Malaria new cases
• Malaria death rate

• Infectious diseases
• Vaccines
• Pediatric
• Climate and health
• Maternal
• Diagnostics and lab testing
• Health IT and data